Proof of Concept, Feasibility, and Efficacy Trials

被引:1
|
作者
Chandelia, Sudha [1 ,2 ]
机构
[1] Atal Bihari Vajpayee Inst Med Sci, Dept Pediat, New Delhi, India
[2] Dr RML Hosp, New Delhi, India
关键词
D O I
10.1097/CCM.0000000000005581
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:E731 / E732
页数:2
相关论文
共 50 条
  • [1] Proof of Concept, Feasibility, and Efficacy Trials Reply
    de Vries, Heder J.
    de Grooth, Harm Jan
    Heunks, Leo M.
    CRITICAL CARE MEDICINE, 2022, 50 (09) : E732 - E734
  • [2] Evaluation of Early Efficacy Endpoints for Proof-of-Concept Trials
    Chen, Cong
    Sun, Linda
    Li, Chih-Lin
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (02) : 413 - 424
  • [3] Proof of efficacy trials: endpoints
    French, JA
    EPILEPSY RESEARCH, 2001, 45 (1-3) : 53 - 56
  • [4] Grow Online: feasibility and proof of concept study
    Chesnut, Ryan P.
    Czymoniewicz-Klippel, Melina
    DiNallo, Jennifer M.
    Perkins, Daniel F.
    JOURNAL OF CHILDRENS SERVICES, 2019, 15 (01) : 25 - 42
  • [5] Clinical trials seek proof of efficacy
    Goldsmith, MF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (23): : 1827 - 1827
  • [6] Proof of efficacy trials: choosing the dose
    Pledger, G
    EPILEPSY RESEARCH, 2001, 45 (1-3) : 23 - 28
  • [7] Proof of efficacy trials: seizure types
    Ben-Menachem, E
    EPILEPSY RESEARCH, 2001, 45 (1-3) : 31 - 34
  • [8] Bayesian Design of Proof-of-Concept Trials
    Fisch, Roland
    Jones, Ieuan
    Jones, Julie
    Kerman, Jouni
    Rosenkranz, Gerd Karl
    Schmidli, Heinz
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (01) : 155 - 162
  • [9] Bayesian Design of Proof-of-Concept Trials
    Roland Fisch
    Ieuan Jones
    Julie Jones
    Jouni Kerman
    Gerd Karl Rosenkranz
    Heinz Schmidli
    Therapeutic Innovation & Regulatory Science, 2015, 49 : 155 - 162
  • [10] Timing of futility analyses for 'proof of concept' trials
    Gould, AL
    STATISTICS IN MEDICINE, 2005, 24 (12) : 1815 - 1835